CVRx
CVRx, Inc. is a privately held medical device company headquartered near Minneapolis that develops implantable baroreceptor neuromodulation systems to treat heart failure and resistant hypertension. The company has conducted randomized controlled clinical trials, obtained CE marking in Europe, secured US regulatory designations and approvals, and operates post-market registries and clinical programs to evaluate safety, performance, and health-economic impact of baroreflex activation therapies.
Industries
Nr. of Employees
medium (51-250)
Products
Implantable baroreceptor activation system
A minimally invasive implantable system consisting of a subclavicular pulse generator, a carotid artery electrode lead, and an external programmer to deliver adjustable electrical stimulation to baroreceptors.
Implantable baroreceptor activation system
A minimally invasive implantable system consisting of a subclavicular pulse generator, a carotid artery electrode lead, and an external programmer to deliver adjustable electrical stimulation to baroreceptors.
Services
Clinical trial conduct and management
Design and execution of multi-center randomized controlled trials and follow-up studies to evaluate safety and efficacy of implantable neuromodulation therapies.
Post-market registry and real-world evidence collection
National registry to capture individual patient safety, utilization, and outcomes data from commercial implantations.
Clinical trial conduct and management
Design and execution of multi-center randomized controlled trials and follow-up studies to evaluate safety and efficacy of implantable neuromodulation therapies.
Post-market registry and real-world evidence collection
National registry to capture individual patient safety, utilization, and outcomes data from commercial implantations.
Expertise Areas
- Baroreceptor neuromodulation
- Clinical trial management and execution (including Phase III)
- Cardiovascular implantable device development
- Regulatory strategy and approvals (CE, FDA EAP/HDE/PMA)
Key Technologies
- Baroreceptor activation / neuromodulation
- Implantable pulse generator systems
- Carotid artery electrode leads
- External device programming systems